IKT Hisse Senedi Fiyat Grafiği
IKT Kâr Dağıtımı
Inhibikase Therapeutics Inc
$2.35
0.85%
$0.02
Kapanışta: Jul 27, 16:00:00 GMT-4
$2.39
1.7%
$0.04
Sonrası Piyasa: Jul 27, 17:41:00 GMT-4
Geri
Inhibikase Therapeutics Inc (IKT) Kâr Dağıtımı
Henüz Veri YokÖnemli İstatistikler
Önceki Kapanış
$2.33
Açılış fiyatı
$2.36
Günün Aralığı
$2.31 - $2.39
52 haftalık aralık
$1.33 - $2.39
İşlem hacmi
507.3K
Ort.Hacim
1.0M
Dividend yield
--
EPS (TTM)
-1.15
Piyasa Değeri
$315.5M
IKT nedir?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
